Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019

IMPORTANCE: The US spends far more on brand-name prescription drugs than other comparable countries. However, studies of prescription drug spending in the US are often limited because there can be substantial differences in the confidential rebates that drug manufacturers pay to Medicaid vs other pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Clemans-Cope, Lisa, Epstein, Marni, Banthin, Jessica, Kesselheim, Aaron S., Hwang, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857139/
https://www.ncbi.nlm.nih.gov/pubmed/36637815
http://dx.doi.org/10.1001/jamahealthforum.2022.5012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857139/
https://www.ncbi.nlm.nih.gov/pubmed/36637815
http://dx.doi.org/10.1001/jamahealthforum.2022.5012

Ejemplares similares